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Introduction: Spinal cord injury (SCI) involves a primary trauma and secondary cellular
processes that can lead to severe damage to the nervous system, resulting in long-term
spinal deficits. At the cellular level, SCI causes astrogliosis, of which glial fibrillary acidic
protein (GFAP) is a major index.
Objective: The aim of this study was to investigate the neuroprotective effects of
Lavandula angustifolia (Lav) on the repair of spinal cord injuries in Wistar rats.
Materials and Methods: Forty-five female rats were randomly divided into six groups
of seven rats each: the intact, sham, control (SCI), Lav 100, Lav 200, and Lav 400
groups. Every week after SCI onset, all animals were evaluated for behavior outcomes
by the Basso, Beattie, and Bresnahan (BBB) score. H&E staining was performed
to examine the lesions post-injury. GFAP expression was assessed for astrogliosis.
Somatosensory evoked potential (SEP) testing was performed to detect the recovery
of neural conduction.
Results: BBB scores were significantly increased and delayed responses on sensory
tests were significantly decreased in the Lav 200 and Lav 400 groups compared to the
control group. The greatest decrease of GFAP was evident in the Lav 200 and Lav 400
groups. EMG results showed significant improvement in the hindlimbs in the Lav 200 and
Lav 400 groups compared to the control group. Cavity areas significantly decreased and
the number of ventral motor neurons significantly increased in the Lav 200 and Lav 400
groups.
Conclusion: Lav at doses of 200 and 400mg/kg can promote structural and functional
recovery after SCI. The neuroprotective effects of L. angustifolia can lead to improvement
in the contusive model of SCI in Wistar rats.
Keywords: spinal cord injury (SCI), Lavandula angustifolia, neuroprotection, Basso Beattie and Bresnahan (BBB),
glial fibrillary acidic protein (GFAP), somatosensory evoked potential (SEP)
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INTRODUCTION
There are ∼200,000 spinal cord injuries (SCI) in the United
States annually, and the vast majority are caused by car accidents
(Sekhon and Fehlings, 2001). SCI can involve severe damage
to the motor, sensory, and autonomic nervous systems and
their function, which may lead to paraplegia, tetraplegia, or
other severe disabilities (Margaret, 2008). The pathogenesis of
SCI after the primary trauma plays an important role in initial
tissue disruption, and the subsequent initiation of a series of
secondary cellular processes beyond the injury site can lead to
long-term spinal deficits and disabilities (Beattie et al., 2002;
Dumont et al., 2002). Increased oxidative stress (Azbill et al.,
1997), activation of redox transcription factors, and elevated
expression of inflammatory mediators may be some of the most
important factors (Popovich and Jones, 2003) in the promotion
of secondary injury after SCI.
Astrogliosis is a cellular response that creates a barrier to
axonal regeneration, and the major index of astrogliosis is
marked upregulation of glial fibrillary acidic protein (GFAP;
Bharne et al., 2013). Therapeutic strategies attempt to attenuate
astrogliosis during the initial phase after SCI (Labombarda
et al., 2011). SCI results in increased tissue oxidative stress and
production of reactive oxygen species (ROS; Azbill et al., 1997),
and antioxidant protection after SCI has improved outcomes in
experimental animals (Kamencic et al., 2001).
There has been interest in finding natural agents that may
help to prevent the inflammation and degeneration of neural
cells in SCI. A well-known herbal drug that has demonstrated
antioxidant effects is lavender, or Lavandula angustifolia Mill.
(Lamiaceae). Commonly known in Iran as “Ostokhoddous,”
L. angustifolia is a widely distributed aromatic herb (Omidbeigi,
2006). It has been used widely for nervous system problems in
Iranian traditional medicine (Avicenna, 1991), and it has recently
been demonstrated that it has important effects on the central
and peripheral nervous systems, including anti-inflammatory,
anti-apoptosis, antioxidant, antimutant, and neuroprotective
effects (Kayvan Yaghoobi et al., 2015). Gas chromatography-mass
spectrometry analysis extraction of L. officinalis L. from Urmia,
Iran, showed totals of 60 and 100 compounds, respectively,
in 96 and 70% ethanol solvent extractions (Saadatian et al.,
2013). The most abundant constituents observed in ethanol
96% extraction included ethane 29.80%,methanecarboxylic acid
(9.01%), p-Vinylguaiacol (4.45%), pentadecanoic acid (3.67%),
and dimethylamine, N,N-Dimethyl methanesulfonamide (2.06%;
Saadatian et al., 2013). Yuanyuan et al. identified 17 compounds
in lavender from Xinjiang, China, with linalool (44.54%),
geraniol (11.02%), lavandulyl acetate (10.78%), 3,7-dimethyl-
2, 6-octadien-1-ol (10.35%), and isoterpineol (6.75%) as the
main components (Yuanyuan et al., 2008). It is known that
linalool is responsible for important therapeutic effects (Peana
et al., 2003, 2004). Each of these constituents can vary
significantly in oils derived from different cultivars, and these
variations can affect the medical properties; therefore, this
study aimed to assess the effect of L. angustifolia extract
from Iran on SCI. We hypothesized that L. angustifolia
may play a role in preventing the harmful effects and
neural damage triggered by SCI, and may promote axonal
regeneration.
MATERIALS AND METHODS
Subjects
Adult femaleWistar rats (Pastor, Tehran) were maintained under
controlled conditions. All animals were acclimatized to the
facility for 7 days prior to starting the experiments. Guidelines
and ethical codes for laboratory animal care and handling was
followed according to those set by the Iranian Ministry of Health
and Medical Education.
All surgical procedures were performed under aseptic
conditions. Following SCI surgery, three animals were housed
per cage and maintained on a 12/12-h light/dark cycle, under
controlled temperature (21 ± 2◦C) and relative humidity
(30–40%). Food and water were provided ad libitum.
Spinal Cord Injury (SCI)
Traumatic spinal injury was induced with the weight-drop device
developed at Baqiyatallah University (Gruner, 1992). Briefly,
the rats (9–10 weeks old at time of injury; weight 225–275 g)
were anesthetized with pentobarbital (40mg/kg) administered
intraperitoneally. The fur above the vertebral column was cleared
using clippers, and cleaned with Betadine solution. A 20-mm
midline incision was made in the thoracic region, and the
vertebral column was exposed. A laminectomy was performed
at the T10 vertebral level, exposing the dorsal cord surface with
the dura remaining intact. The paravertebral muscle fascia was
penetrated, and the muscles were peeled laterally using blunt
dissection forceps. The spinal cord segment at the T8-T9 level
was exposed by total laminectomy. The vertebral column was
stabilized with angled clamps on the T8 and T12 vertebrae
(Gruner, 1992; Basso et al., 1996). A 10 g weight (stainless steel
rod, 3mm diameter tip) was allowed to drop vertically from
12.5mm (2.5 cm) onto the center of the exposed spinal cord,
resulting in a moderate spinal cord injury (SCI). The impact rod
was removed immediately following the injury, and the muscles
and the incision were closed in layers using catgut. Following
the surgery, the animals were placed on heating pads maintained
at 37◦C. The rats were monitored until they recovered from
anesthesia, and were then returned to their home cages. The
sham-operated rats received the same surgical procedures but
sustained no impact injury (i.e., the spinal cord contusion was
not performed).
Plant Collection and Extraction
The plants were obtained from commercial sources. The dried
leaf powder of L. angustifoliawasmacerated at room temperature
in 70% ethanol (1 g/10ml) and extracted for a week. On
the seventh day, the ethanolic extract was filtered and the
extract was evaporated under reduced pressure to remove the
ethanol. The dry extract was suspended in normal saline. In
this way, alcoholic extracts of L. angustifolia (Lav) at minimum
(100mg/kg), moderate (200mg/kg), and maximum (400mg/kg)
doses were prepared.
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Drug Treatments and Experimental Outline
The rats were divided into six groups as follows. Group I: intact
(n = 6), group II: sham-operated/saline (n = 7), group III:
control group subjected to SCI (n = 7), group IV: SCI treated
with Lav 100mg/kg (n = 7), group V: SCI treated with Lav
200mg/kg (n = 10), and group VI: SCI treated with Lav
400mg/kg (n = 8). Lav and saline, respectively, were injected
intraperitoneally in the Lav and sham groups, starting 1 day after
injury, then daily until the fourteenth day.
Neurological Examination of Functional
Recovery
The Basso, Beattie, and Bresnahan (BBB) scale was used to
assess neurological function in an open-field motor test. The BBB
scale is a 21-point scale ranging from 1 (indicating no hindlimb
movement) to 21 (indicating normal hindlimb function). It
rates locomotion based on various aspects of hindlimb function,
such as weight support, stepping ability, coordination, and toe
clearance. All functional scores were obtained on post-injury
days 1, 7, 14, 21, 28, 35, 42, 49, and 56 by two individuals blinded
to treatment. Behavioral tests for the evaluation of pain were
performed by means of the hot-water test for the hindlimbs
before and after SCI; scores were obtained on post-injury days
1, 7, 14, 21, 28, 35, 42, 49, and 56.
Electrophysiological Evaluations
One day before the sacrifice of the animals, intramuscular EMG
recording needles were inserted bilaterally into the hindlimb
flexor muscles to record the 10-s electrical potential generated by
the muscle cells. After recording, we compressed 10 to 1 s using
EMG software in order to acquire the recruitment index of motor
units.
Histological Preparation and
Morphometric Studies
Eight weeks after the surgery and 1 day after electrophysiological
evaluation, all rats were anesthetized (100mg/kg sodium
pentobarbital intraperitoneally), then were intracardially
perfused with 0.9% saline followed by 10% buffered formalin.
A 1 cm section of the spinal cord from the lesion’s epicenter at
T8 was dissected, post-fixed in 10% buffered formalin overnight
and cryo-protected in 30% sucrose for 48 h. Serial 10µm-thick
sagittal sections were collected. All sections were processed for
hematoxylin and eosin (H&E) staining and examined under
light microscopy. The lesion area, including both the cavity
and the surrounding damaged tissue, as well as gray and white
matter volume and the number of lower motor neurons and
positive GFAP astrocyte perikaryons, were then measured with
image-analyzing software (Image-Pro Express, version 6.0.0.319,
Media Cybernetics, Silver Spring, MD, USA). Three to five
sections from each tissue specimen were counted, and mean
values were obtained for each tissue. Only those cells that showed
clearly discernible nucleus were counted. All cell-counting
analyses were carried out by two observers blind to the specific
experimental conditions of the analyzed tissues, on images
acquired at 40× and 400×magnifications.
Immunohistochemical Analysis
Standard immunocytochemistry for the glial-scar GFAP was
performed on all of the sections for each group. All cell-counting
analyses were carried out on images acquired at 40× and 400×
magnifications. The paraffin sections were dried in an air oven
(58◦C for 2∼4 h. The tissues were dewaxed with xylene and
hydrated with alcohol. After the sections were washed with PBS,
antigen retrieval solution (0.01 mol/L sodium citrate, pH = 6.0)
was added; then they were boiled at a constant temperature of
95◦C 15min. When the sections were naturally cooled down,
PBS was used again to wash them. The tissues were incubated
with H2O2 (3%) at room temperature for 10min. They were
washed with PBS, and 10% fetal calf serum was added for 30min
then the sections were washed with PBS thrice. Primary antibody
(Abcam Plc, Cambridge, UK), namely anti-GFAP (1: 50), was
added for the following incubation in humidified chamber at 4◦C
overnight. Avidin Biotin secondary antibody conjugated with
HRP was added, incubation at 37◦C was kept for 1.5 h. The
samples were washed with PBS thrice. Finally DAB cromogen
were used for 10min and hematoxylin counterstaining (30 s)
were successively performed. After dehydration and drying, the
sections were mounted with Entelan. We used an ECLIPSE
5Oi microscope (Nickon ECLIPSE 5Oi Listed 4N75 inspection
equipment 116284) to achieve better resolution for analyzing the
images.
Statistical Analysis
All data, except for BBB and sensory function, were analyzed
by one-way analysis of variance (ANOVA) followed by post-
hoc Tukey and Dennett’s multiple-comparisons tests. BBB and
sensory function were analyzed by two-way ANOVA, followed by
Bonferroni post-tests. The obtained data were presented as mean
values ± standard error of mean (mean ± SEM); the treatment
means were compared using the Tukey post-hoc test. A statistical
probability of P < 0.05 was considered significant. All tests
were performed using GraphPad Prism version 5.00 forWindows
(GraphPad Software, San Diego, CA, USA).
RESULTS
Effects of L. angustifolia Extract on
Locomotor Recovery after SCI
While SCI resulted in immediate paraplegia (loss of hindlimb
movement), the sham-operated rats showed no significant
changes in locomotion scores (BBB) in comparison with the
intact animals. Intraperitoneal Lav administration (100, 200, or
400mg/kg) 1 day after injury significantly improved locomotor
function in the treated rats compared to the control group.
Application of two-way ANOVA showed significant interactions
between variables, such as Lav treatment (100, 200, and
400mg/kg), and time [F(40, 272) = 33.80, P < 0.0001].
Application of the post-hoc Bonferroni multiple-comparisons
test revealed significant improvement in motor function
following Lav treatment on day 14 post-injury in the Lav 200
group (p < 0.01), and on days 21, 28, 35, 42, 49, and 56 in the
Lav 400 group (p < 0.001). The Lav 100 group showed improved
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locomotor activity after day 28 (p < 0.05). There were significant
differences between the doses of 100 and 400mg/kg from day 14
(p < 0.05) until day 56 (p < 0.001). The results showed no
significant differences between the Lav doses of 200mg/kg and
400mg/kg (Figure 1).
Effects of L. angustifolia Extract Treatment
on Sensory Recovery after SCI in the
Hot-Water Test
Statistical evaluations revealed that the mean latency time of
response to painful stimulus (delayed response) was significantly
decreased in the Lav groups vs. the control (SCI) group.
Application of two-way ANOVA showed significant interactions
between variables, such as Lav treatment (100, 200, or 400mg/kg)
and number of days post-injury [F(40, 272) = 9.59, P < 0.0001].
Application of post-hoc Bonferroni’s multiple-comparisons test
FIGURE 1 | Administration of L. angustifolia extract improves motor
and sensory function impairment in the rat spinal cord contusion
model. Administration of L. angustifolia extract (i.p.) daily for 14 consecutive
days post-injury significantly improved BBB scores (A) and sensory function
(with decreased delayed response in the hot-water test) (B) Data are
represented as mean ± SEM. (A) ###shows significant difference between
Lav 400 and controls (SCI) (P < 0.001). $$ and $$$ show significant
differences between Lav 200 and controls (SCI) (P < 0.01 and P < 0.001,
respectively). * and **show significant differences between Lav 100 and
controls (SCI) (P < 0.05 and P < 0.01, respectively). (B)*, **, and ***show
significant differences between Lav 400 and SCI (P < 0.05, P < 0.01, and
P < 0.001, respectively).
revealed significant improvement in sensory function following
Lav treatment on post-injury days 7, 14, 21, 28, 35, 42, 49,
and 56. There was better sensory recovery with the highest
Lav dose (400mg/kg), but there were no significant differences
between the other doses (Figure 1B). There were no significant
differences between Lav 400 and Lav 200, or between Lav 100
and SCI, but there were significant differences between Lav 400
and the Lav 100 and SCI groups (P < 0.001).
Electrophysiological Evaluations
Statistical analysis showed that the means of the recruitment
index were increased significantly for the left [F(5, 34) = 25.92,
P < 0.0001] and right [F(5, 34) = 18.17, P < 0.0001] hindlimbs
in the Lav groups vs. the control (SCI) group. Application of
Dennett’s post-hocmultiple-comparisons test revealed significant
improvements in electrophysiological activity of the right
hindlimbs following treatment with Lav 200mg/kg (P <
0.001) and 400mg/kg (P < 0.0001). This test also revealed
significant improvements in the electrophysiological activity of
the left hindlimbs following Lav 200 and 400mg/kg (P <
0.0001) treatments (Figure 2A). Although, there was some
improvement with Lav 100mg/kg in the right and left hindlimbs,
there were no significant differences with the control group.
There were significant differences between Lav 400 and Lav
100 in the left (p < 0.01) and right (p < 0.001)
hindlimbs.
Histomorphological Evaluations
Statistical evaluations revealed that the mean cavity size was
significantly reduced in the Lav 200 and Lav 400 treatment groups
[F(5, 34) = 37.32, P < 0.0001] compared to the control group
(Figure 2B). No statistically significant difference was found in
cavity volume between the Lav 200 and Lav 400 groups, but there
were significant differences between Lav 100 and the Lav 200
group (P < 0.05) and the Lav 400 (P < 0.01) group.
Application of one-way ANOVA showed significant
differences between the sham, Lav-treated, and control groups
in the number of ventral horn motor neurons (VHMNs)
[F(5, 34) = 30.73, P < 0.0001]. Application of Dunnett’s post-hoc
multiple-comparisons test revealed a significant increase in
the number of VHMNs in the Lav 200 (p < 0.05) and Lav
400 (p < 0.01) treatment groups compared to the control
group (Figures 3A, 5). No significant differences were observed
between Lav 100 and Lav 200.
GFAP Expression after SCI
Strong immunostaining for GFAP was demonstrated in the
control group (Figures 3B, 4); however, this activation was
significantly attenuated in the Lav groups [F(5, 34) = 28.18,
P < 0.0001]. Application of Bonferroni’s post-hoc multiple-
comparisons test revealed a significant decrease in GFAP in the
Lav 200 and Lav 400 groups (p < 0.001; Figure 3B). These results
revealed that Lav can abate the activation of astrocytes after SCI.
No statistically significant difference was found in GFAP between
the Lav 100, Lav 200, and Lav 400 groups.
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FIGURE 2 | Administration of L. angustifolia improved locomotor and
EMG impairment in the rat spinal cord contusion model. Intraperitoneal
administration of L. angustifolia extract daily for 14 consecutive days
post-injury significantly improved the EMG results (A) and histomorphological
evaluations (B). Data are represented as mean±SEM. (A) ** and *** show
significant differences of the Lav 200 and 400 groups compared to the control
group (SCI) (P < 0.01 and P < 0.001, respectively). $$ and $$$ show
significant differences of the Lav 200 and 400 groups with the Lav 100 group
(P < 0.01 and P < 0.001, respectively). (B) ***shows significant differences of
the Lav 200 and 400 groups compared to the control group (SCI) (P < 0.001,
respectively). # and ## show significant differences of the Lav 200 and 400
groups compared to the Lav 100 group (P < 0.01 and P < 0.001,
respectively). (Per 35625µm2).
DISCUSSION
L. angustifolia has neuroprotective and neurotrophic effects,
including enhancement of functional recovery (Vakili
et al., 2013), suggesting that it has therapeutic effects on
FIGURE 3 | Administration of L. angustifolia increased the number of
VHMNs (A) and decreased GFAP expression in the rat spinal cord
contusion model. Intraperitoneal administration of L. angustifolia extract daily
for 14 consecutive days post-injury significantly increased the number of
VHMNs (A) and decreased the levels of GFAP expression in the rat spinal cord
contusion model (B). Data are represented as mean ± SEM. (A) * and ** show
significant differences of the Lav 200 and Lav 400 groups with the control (SCI)
group (P < 0.05 and P < 0.01, respectively). (Per 5700µm2). (B) *** shows
significant differences of the Lav 200 and Lav 400 groups with the control (SCI)
group (P < 0.001). (Per 35625µm2).
neurodegenerative disease (Peana et al., 2003, 2006; Vakili
et al., 2013) and antinociceptive effects on SCI (Peana et al.,
2004). We evaluated the therapeutic potential of L. angustifolia
for SCI in a conventional animal model. Intraperitoneal
L. angustifolia improved motor dysfunction following that
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FIGURE 4 | Transverse section of spinal cord showing the ventral horn gray matter at the T12-L1 level for all groups on day 56 GFAP-stained images.
Red arrows indicate the GFAP astrocytes. Yellow arrows indicate VHMNs. Decreased GFAP astrocytes and increased VHMNs are evident. Bar in 40X = 100
micrometer and Bar in 200X = 50 micrometer. (ECLIPSE 5Oi microscope).
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FIGURE 5 | Administration of L. angustifolia improved Histomorphological evaluation results in the rat spinal cord contusion model. Transverse section
of spinal cord showing the ventral horn gray matter from spinal cord at the level of T12-L1 of all groups which evaluated in this study at day 56. H&E staining showed
shrinkage and decrease of Ventral Horn Motor Neurons of control (SCI) in compare with Lav 100, 200 and 400 mg/Kg/Day. Yellow arrows illustrating the Ventral Horn
Motor Neurons and blue arrows show central canal. L. angustifolia extract increased the number of VHMNs and improved the shape of central canal. Bar in 40X =
100 micrometer and Bar in 200X = 50 micrometer. (ECLIPSE 5Oi microscope).
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administration of L. angustifolia extract itself improves the
behavioral and cellular outcomes in the rat contusion SCI
model.
SCI is a complex neuropathological process involving a
variety of neurochemical, cellular, andmolecular events. Calcium
overload (Dumont et al., 2001), extracellular accumulation of
glutamate (Beattie et al., 2002), and induction of oxidative stress
(Azbill et al., 1997; Aksenova et al., 2002) are the results of
the primary injury to the spinal cord after the initial trauma.
Increased oxidative stress after spinal cord trauma can lead to
secondary processes, such as impaired activity of membrane
enzymes (Aksenova et al., 2002; Martin and Liu, 2002) and
over-expression of inflammatory mediators, which potentiates
secondary injury to the spinal cord via a variety of processes,
such as activation of microglia and stimulation of astrocyte
proliferation, which in turn can even further increase the
generation of neurotoxic ROS (Dumont et al., 2001; Popovich
and Jones, 2003).
It has been demonstrated that administration of L. angustifolia
extract could alleviate the extracellular accumulation of
glutamate (Büyükokurog˘lu et al., 2003) and could decrease
oxidative stress (Peana et al., 2006; Vakili et al., 2013), and it
has reported that linalool (a constituent of L. angustifolia) has
antinociceptive effects (Peana et al., 2003).
Ideally, therapeutic strategies for SCI would incorporate
both neuroprotective and neurotrophic properties. Acute
neuroprotection could preserve neurologic function by
maintaining axonal function and preventing cell death. Ionic
flux, alterations in local blood flow, and inflammation contribute
to the initial and evolving secondary neurologic injuries, and
therapeutic strategies have attempted to reduce excitotoxicity
with glutamate receptor antagonists (Rosenberg et al., 1999;
Wada et al., 1999) and to inhibit nitric oxide synthase (Satake
et al., 2000), block apoptosis (Schumacher et al., 2000), and
modulate inflammatory responses (Schwartz et al., 1999).
Protection against the progression of secondary injury to
the spinal cord neurons appears to be one of the most
effective therapeutic strategies for limiting tissue injury and
improving the outcome of spinal cord trauma (Dumont
et al., 2002). Lav improved locomotion and increased VHMNs;
therefore, it appears that it could play an important role
in treatment strategies. As neuroprotection could preserve
neurologic function by preventing cell death, one of the most
important roles of Lav could be its neuroprotective effects. We
believe that calcium-calmodulin may play an important role in
the neuroprotective effects of Lav (Kayvan Yaghoobi et al., 2015).
CONCLUSION
A non-immunosuppressive L. angustifolia extract improved
motor dysfunction in a SCI contusion model, and promoted
morphological improvement.While further studies are needed to
clarify the mechanism of action in SCI models, the present results
suggest that L. angustifolia extract may have therapeutic potential
for treating patients with spinal cord injuries.
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